Aktie 300642 TELLGEN CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Tellgen Corporation

Aktien

300642

CNE100002P42

300642

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 28.06.2024 		% 5 Tage % 1. Jan.
11,64 CNY -1,19 % Intraday Chart für Tellgen Corporation -1,69 % -34,05 %
15.05. Tellgen Corporation beschließt Bardividende für 2023 CI
22.04. Tellgen Corporation meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Shanghai Maishi Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Shanghai Zhangke Lingyi Qifan Venture Capital Center (Limited Partnership), Tellgen Corporation
Tellgen Corporation Approves Cash Dividend for 2023
Shanghai Maishi Biotechnology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Shanghai Zhangke Lingyi Qifan Venture Capital Center (Limited Partnership), Tellgen Corporation
Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on February 6, 2024.
Tellgen Corporation's Equity Buyback announced on February 6, 2024, has closed with 1,946,150 shares, representing 1.2% for CNY 25.98 million.
Tellgen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on February 6, 2024.
Tellgen Corporation announces an Equity Buyback for CNY 50 million worth of its shares.
Tellgen Corporation authorizes a Buyback Plan.
Tellgen Corporation Announces Board Appointments
Tellgen Corporation Reports Earnings Results for the Nine Months Ended September 30, 2023
Tellgen Corporation, Shanghai Tellgen Diagnostic Technology Co., Ltd., Shanghai Maishi Jingwu Enterprise Management Partnership Enterprise (Limited Partnership), Yao Beier, Niu Zhengxiang and Zhan Hong agreed to acquire additional 5.71% stake in Shanghai Maishi Biotechnology Co., Ltd. from Wu Liang for CNY 1.4 million.
Tellgen Corporation Reports Earnings Results for the Half Year Ended June 30, 2023
Tellgen Corporation Approves Cash Dividend for 2022, Payable on 23 May 2023
Tellgen Corporation Proposes Final Cash Dividend for 2022
Tellgen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Tellgen Corporation Reports Earnings Results for the Nine Months Ended September 30, 2022
Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on October 27, 2021.
Tellgen Corporation's Equity Buyback announced on October 27, 2021, has expired with 1,062,840 shares, representing 0.65% for CNY 25.43 million.
Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on October 27, 2021.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 300642 Aktie
  4. Nachrichten Tellgen Corporation
  5. Andere Sprachen